Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.
Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.
复制标题
DOI:
10.1016/j.molonc.2014.03.008
复制
发表时间:
2014-06
影响因子:
6.6
通讯作者:
Lindskog C
中科院分区:
文献类型:
--
作者:
O'Hurley G;Sjöstedt E;Rahman A;Li B;Kampf C;Pontén F;Gallagher WM;Lindskog C
The use of immunohistochemistry (IHC) in clinical cohorts is of paramount importance in determining the utility of a biomarker in clinical practice. A major bottleneck in translating a biomarker from bench‐to‐bedside is the lack of well characterized, specific antibodies suitable for IHC. Despite the widespread use of IHC as a biomarker validation tool, no universally accepted standardization guidelines have been developed to determine the applicability of particular antibodies for IHC prior to its use. In this review, we discuss the technical challenges faced by the use of immunohistochemical biomarkers and rigorously explore classical and emerging antibody validation technologies. Based on our review of these technologies, we provide strict criteria for the pragmatic validation of antibodies for use in immunohistochemical assays. Immunohistochemistry is an important tool for biomarker development. Few potential immunohistochemistry biomarkers reach the clinical utility. We describe the various factors influencing the IHC process. We discuss classical and emerging antibody validation technologies. We provide recommended work‐flows for proper antibody validation.
登录
查看更多内容
影响因子:
45.3
作者:
Bartlett, John M. S.;Bloom, Kenneth J.;Rea, Daniel
通讯作者:
Rea, Daniel
影响因子:
46.9
作者:
Cho, Seung Woo;Kim, Sojung;Kim, Jin-Soo
通讯作者:
Kim, Jin-Soo
影响因子:
7.3
作者:
Debiec-Rychter, M;Wasag, B;Sciot, R
通讯作者:
Sciot, R
影响因子:
7.4
作者:
Bartlett, John M. S.;Thomas, Jeremy;Chetty, Udi
通讯作者:
Chetty, Udi
影响因子:
7.3
作者:
CATTORETTI, G;PILERI, S;RILKE, F
通讯作者:
RILKE, F